Take action, page-50

Not sure if it's been mentioned here, but for anyone who has contacted Geoff Hollis / the company (or have been involved in ASX listed med trials) directly, but given the ASX tightening of the rules, the enrollment of a new patient is not deemed to be material and as such doesn't warrant an announcement.

My understanding is the trial is expected to contain a minimum of 15 patients. My hope would be that meeting the minimum 15 patients would warrant an announcement as it means they can complete the trial with this amount (although not confirmed). Long story short, the patient enrollment would be somewhere between 1 and 14, and hopefully towards the latter. Given there are 3 live sites with a 4th to go online shortly (operating across 3 states), it's really just a matter of patience. I know the market is hungry to know the enrollment numbers, however I don't believe we will until it crosses a threshold as per ASX announcement rules. #DYOR etc